Abstract
Pemigatinib is an oral, selective, potent, competitive inhibitor acting on fibroblast growth factor receptor (FGFR)1, FGFR2, and FGFR3, which has obta......
小提示:本篇文献需要登录阅读全文,点击跳转登录